Phone

240-403-4212

Email
Address

1 Research Court, Suite 450 Rockville, MD 20850

Investor Relations

Corporate Profile

Shuttle Pharmaceuticals is a clinical-stage biopharmaceutical company leveraging our proprietary technology to develop novel therapies that are designed to cure cancer. Led by a best-in-class management team with significant experience in cancer treatment, we are developing a pipeline of revolutionary radiation sensitizers and immunotherapy assisting product candidates.

Events

Corporate Presentation

 

 

Clinical Cancer Research

‚Äč

 

Phase I and Pharmacology study of Ropidoxuridine (IPdR) as prodrug iododeoxyuridine-mediated tumor radiosensitization in advanced GI cancer undergoing radiation

Latest News